prof. dr. Fritz Offner
- Work address
-
C. Heymanslaan 10, ingang 12 - verdieping 6
9000 Gent - Fritz.Offner@UGent.be
- ORCID iD
-
0000-0003-4690-3603
Show
Sort by
-
- Journal Article
- open access
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
-
- Journal Article
- open access
The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study
-
- Journal Article
- open access
Nucleic Acid Biomarkers in Waldenstrom Macroglobulinemia and IgM-MGUS: Current Insights and Clinical Relevance
-
A unique phenotype of longitudinal extensive transverse myelitis in autoimmune lymphoproliferative syndrome
-
- Journal Article
- A1
- open access
Real-world estimation of first- and second-line treatments for diffuse large B-cell lymphoma using health insurance data : a Belgian population-based study
-
Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma
-
Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma
-
Comparison of the effectiveness and safety of the oral selective inhibitor of nuclear export, selinexor, in diffuse large B cell lymphoma subtypes
-
- Journal Article
- A1
- open access
Prolonged remissions after nivolumab plus gemcitabine/oxaliplatin in relapsed/refractory T-cell lymphoma
-
Identifying patients with chronic lymphocytic leukemia without need of treatment : end of endless watch and wait?